Yahoo Web Search

Search results

1. • February 28, 2024

     • DUBLIN, Feb. 14, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 full year and fourth quarter financial results on Wednesday, February 28, 2024, after the close of the U.S. financial markets.
     Reference:

     Jazz Pharmaceuticals to Report 2023 Full Year and Fourth ...

2. People also ask

   Does Jazz Pharmaceuticals (jazz) have financial guidance for 2023?

   • DUBLIN, March 1, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2022 and provided financial guidance for 2023.

   Jazz Pharmaceuticals Announces Full Year and Fourth

   www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-full-year-and-fourth-quarter-2022-financial-results-and-provides-2023-financial-guidance-301760085.html

   See all results for this question

   When will Jazz Pharmaceuticals report its 2023 first quarter financial results?

   • Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on May 10, 2023 April 26, 2023 PDF Version DUBLIN, April 26, 2023/PRNewswire/ -- Jazz Pharmaceuticals plc(Nasdaq: JAZZ) today announced that it will report its 2023 first quarter financial results on Wednesday, May 10, 2023, after the close of the U.S.financial markets.

   Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on

   investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-report-2023-first-quarter-financial-results

   See all results for this question

   What time does Jazz Pharmaceuticals hold a conference call?

   • Conference Call Details Jazz Pharmaceuticals will host an investor conference call and live audio webcast today at 4:30 p.m. ET ( 9:30 p.m. GMT) to provide a business and financial update and discuss its 2022 full year and 4Q22 results and 2023 guidance.

   Jazz Pharmaceuticals Announces Full Year and Fourth

   www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-full-year-and-fourth-quarter-2022-financial-results-and-provides-2023-financial-guidance-301760085.html

   See all results for this question

   Who are the investors of Jazz Pharmaceuticals plc?

   • Investors: Andrea N. Flynn, Ph.D. Vice President, Head, Investor Relations Jazz Pharmaceuticals plc InvestorInfo@jazzpharma.com Ireland+353 1 634 3211 U.S.+1 650 496 2717 Media Contact: Kristin Bhavnani Head of Global Corporate Communications Jazz Pharmaceuticals plc CorporateAffairsMediaInfo@jazzpharma.com Ireland+353 1 637 2141

   Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on

   investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-report-2023-first-quarter-financial-results

   See all results for this question

3. finance.yahoo.com › news › jazz-pharmaceuticalsJazz Pharmaceuticals to Report 2023 Full Year and Fourth ...

   finance.yahoo.com › news › jazz-pharmaceuticals

   • Cached

   Feb 14, 2024 · DUBLIN, Feb. 14, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 full year and fourth quarter financial results on Wednesday,...

4. www.prnewswire.com › news-releases › jazzJazz Pharmaceuticals Announces Full Year and Fourth Quarter ...

   www.prnewswire.com › news-releases › jazz

   • Cached

   Feb 28, 2024 · DUBLIN, Feb. 28, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2023 and provided guidance for...

5. Videos

   • 

     benzinga.com

     Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues? - Jazz Pharmaceuticals (NASDAQ:JAZZ)

     Aug 9, 2023

   • 

     nasdaq.com

     RBC Capital Maintains Jazz Pharmaceuticals (JAZZ) Outperform Recommendation

     Aug 10, 2023

   • 

     benzinga.com

     Jazz Pharmaceuticals Announces Q3 2022 Financial Results, Raises Total Revenue Guidance - Jazz Pharmaceuticals (NASDAQ:JAZZ)

     Nov 10, 2022

   View all

6. investor.jazzpharma.com › financial-informationQuarterly Results | Jazz Pharmaceuticals plc

   investor.jazzpharma.com › financial-information

   • Cached

   Investor Contacts. Andrea N. Flynn, Ph.D. Vice President, Head, Investor Relations. investorinfo@jazzpharma.com Ireland: +353 1 634 3211 U.S.: +1 650 496 2717

7. investor.jazzpharma.com › news-releases › news-releaseJazz Pharmaceuticals to Report 2023 Third Quarter Financial ...

   investor.jazzpharma.com › news-releases › news-release

   • Cached

   Oct 25, 2023 · DUBLIN, Oct. 25, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 third quarter financial results on Wednesday, November 8, 2023, after the close of the U.S. financial markets.

8. www.prnewswire.com › news-releases › jazzJazz Pharmaceuticals Announces Full Year and Fourth Quarter ...

   www.prnewswire.com › news-releases › jazz

   • Cached

   Mar 1, 2023 · DUBLIN, March 1, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2022 and provided financial guidance...

9. investor.jazzpharma.com › news-releases › newsJazz Pharmaceuticals to Report 2023 First Quarter Financial ...

   investor.jazzpharma.com › news-releases › news

   • Cached

   Apr 26, 2023 · Download PDF. DUBLIN, April 26, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 first quarter financial results on Wednesday, May 10, 2023, after the close of the U.S. financial markets.